Selected research
Industry Research
Natural APIs (Active Pharmaceutical Ingredients) Industry Research Report 2026
Market perspective
The global Natural APIs (Active Pharmaceutical Ingredients) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Natural APIs (Active Pharmaceutical Ingredients) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Natural APIs (Active Pharmaceutical Ingredients) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Natural APIs (Active Pharmaceutical Ingredients) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Natural APIs (Active Pharmaceutical Ingredients) include Sanofi SA, Novartis AG, Roquette Freres SA, Kothari Phytochemicals, GSK plc, Evonik Industries AG, Centroflora Group, Cargill and BASF SE, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Natural APIs (Active Pharmaceutical Ingredients) market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Natural APIs (Active Pharmaceutical Ingredients) Market by Company
Sanofi SA
Novartis AG
Roquette Freres SA
Kothari Phytochemicals
GSK plc
Evonik Industries AG
Centroflora Group
Cargill
BASF SE
Arboris
Natural APIs (Active Pharmaceutical Ingredients) Segment by Type
Terpenoids
Alkaloids
Lignin
Flavonoids
Anthocyanin
Phenolic Acids
Others
Natural APIs (Active Pharmaceutical Ingredients) Segment by Application
Health Products
Biology
Pharmaceuticals
Others
Natural APIs (Active Pharmaceutical Ingredients) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Natural APIs (Active Pharmaceutical Ingredients) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Natural APIs (Active Pharmaceutical Ingredients) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Natural APIs (Active Pharmaceutical Ingredients).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Natural APIs (Active Pharmaceutical Ingredients) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Natural APIs (Active Pharmaceutical Ingredients) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Natural APIs (Active Pharmaceutical Ingredients) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Terpenoids
- Alkaloids
- Lignin
- Flavonoids
- Anthocyanin
- Phenolic Acids
- Others
Applications
- Health Products
- Biology
- Pharmaceuticals
- Others
Companies covered
- Sanofi SA
- Novartis AG
- Roquette Freres SA
- Kothari Phytochemicals
- GSK plc
- Evonik Industries AG
- Centroflora Group
- Cargill
- BASF SE
- Arboris
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Natural APIs (Active Pharmaceutical Ingredients) Market Size (2021-2032)
- 2.2.2 Global Natural APIs (Active Pharmaceutical Ingredients) Sales (2021-2032)
- 2.2.3 Global Natural APIs (Active Pharmaceutical Ingredients) Market Average Price (2021-2032)
- 2.3 Natural APIs (Active Pharmaceutical Ingredients) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Terpenoids
- 2.3.3 Alkaloids
- 2.3.4 Lignin
- 2.3.5 Flavonoids
- 2.3.6 Anthocyanin
- 2.3.7 Phenolic Acids
- 2.3.8 Others
- 2.4 Natural APIs (Active Pharmaceutical Ingredients) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Health Products
- 2.4.3 Biology
- 2.4.4 Pharmaceuticals
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Natural APIs (Active Pharmaceutical Ingredients) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue of Manufacturers (2021-2026)
- 3.4 Global Natural APIs (Active Pharmaceutical Ingredients) Average Price by Manufacturers (2021-2026)
- 3.5 Global Natural APIs (Active Pharmaceutical Ingredients) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Natural APIs (Active Pharmaceutical Ingredients), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Natural APIs (Active Pharmaceutical Ingredients), Product Type & Application
- 3.8 Global Manufacturers of Natural APIs (Active Pharmaceutical Ingredients), Established Date
- 3.9 Global Natural APIs (Active Pharmaceutical Ingredients) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sanofi SA
- 4.1.1 Sanofi SA Company Information
- 4.1.2 Sanofi SA Business Overview
- 4.1.3 Sanofi SA Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sanofi SA Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
- 4.1.5 Sanofi SA Recent Developments
- 4.2 Novartis AG
- 4.2.1 Novartis AG Company Information
- 4.2.2 Novartis AG Business Overview
- 4.2.3 Novartis AG Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Novartis AG Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
- 4.2.5 Novartis AG Recent Developments
- 4.3 Roquette Freres SA
- 4.3.1 Roquette Freres SA Company Information
- 4.3.2 Roquette Freres SA Business Overview
- 4.3.3 Roquette Freres SA Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Roquette Freres SA Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
- 4.3.5 Roquette Freres SA Recent Developments
- 4.4 Kothari Phytochemicals
- 4.4.1 Kothari Phytochemicals Company Information
- 4.4.2 Kothari Phytochemicals Business Overview
- 4.4.3 Kothari Phytochemicals Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Kothari Phytochemicals Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
- 4.4.5 Kothari Phytochemicals Recent Developments
- 4.5 GSK plc
- 4.5.1 GSK plc Company Information
- 4.5.2 GSK plc Business Overview
- 4.5.3 GSK plc Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 GSK plc Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
- 4.5.5 GSK plc Recent Developments
- 4.6 Evonik Industries AG
- 4.6.1 Evonik Industries AG Company Information
- 4.6.2 Evonik Industries AG Business Overview
- 4.6.3 Evonik Industries AG Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Evonik Industries AG Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
- 4.6.5 Evonik Industries AG Recent Developments
- 4.7 Centroflora Group
- 4.7.1 Centroflora Group Company Information
- 4.7.2 Centroflora Group Business Overview
- 4.7.3 Centroflora Group Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Centroflora Group Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
- 4.7.5 Centroflora Group Recent Developments
- 4.8 Cargill
- 4.8.1 Cargill Company Information
- 4.8.2 Cargill Business Overview
- 4.8.3 Cargill Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Cargill Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
- 4.8.5 Cargill Recent Developments
- 4.9 BASF SE
- 4.9.1 BASF SE Company Information
- 4.9.2 BASF SE Business Overview
- 4.9.3 BASF SE Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 BASF SE Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
- 4.9.5 BASF SE Recent Developments
- 4.10 Arboris
- 4.10.1 Arboris Company Information
- 4.10.2 Arboris Business Overview
- 4.10.3 Arboris Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Arboris Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
- 4.10.5 Arboris Recent Developments
5 Global Natural APIs (Active Pharmaceutical Ingredients) Market Scenario by Region
- 5.1 Global Natural APIs (Active Pharmaceutical Ingredients) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Region: 2021-2032
- 5.2.1 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Region: 2021-2026
- 5.2.2 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Region: 2027-2032
- 5.3 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Region: 2021-2032
- 5.3.1 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Region: 2021-2026
- 5.3.2 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Region: 2027-2032
- 5.4 North America Natural APIs (Active Pharmaceutical Ingredients) Market Facts & Figures by Country
- 5.4.1 North America Natural APIs (Active Pharmaceutical Ingredients) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2021-2032)
- 5.4.3 North America Natural APIs (Active Pharmaceutical Ingredients) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Natural APIs (Active Pharmaceutical Ingredients) Market Facts & Figures by Country
- 5.5.1 Europe Natural APIs (Active Pharmaceutical Ingredients) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2021-2032)
- 5.5.3 Europe Natural APIs (Active Pharmaceutical Ingredients) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Natural APIs (Active Pharmaceutical Ingredients) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Natural APIs (Active Pharmaceutical Ingredients) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Natural APIs (Active Pharmaceutical Ingredients) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Natural APIs (Active Pharmaceutical Ingredients) Market Facts & Figures by Country
- 5.7.1 South America Natural APIs (Active Pharmaceutical Ingredients) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2021-2032)
- 5.7.3 South America Natural APIs (Active Pharmaceutical Ingredients) Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Type (2021-2032)
- 6.1.1 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Type (2021-2032)
- 6.2 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Type (2021-2032)
- 6.2.1 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Type (2021-2032)
- 6.3 Global Natural APIs (Active Pharmaceutical Ingredients) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Application (2021-2032)
- 7.1.1 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Application (2021-2032)
- 7.2 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Application (2021-2032)
- 7.2.1 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Application (2021-2032)
- 7.3 Global Natural APIs (Active Pharmaceutical Ingredients) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Natural APIs (Active Pharmaceutical Ingredients) Value Chain Analysis
- 8.1.1 Natural APIs (Active Pharmaceutical Ingredients) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Natural APIs (Active Pharmaceutical Ingredients) Production Mode & Process
- 8.2 Natural APIs (Active Pharmaceutical Ingredients) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Natural APIs (Active Pharmaceutical Ingredients) Distributors
- 8.2.3 Natural APIs (Active Pharmaceutical Ingredients) Customers
9 Global Natural APIs (Active Pharmaceutical Ingredients) Analyzing Market Dynamics
- 9.1 Natural APIs (Active Pharmaceutical Ingredients) Industry Trends
- 9.2 Natural APIs (Active Pharmaceutical Ingredients) Industry Drivers
- 9.3 Natural APIs (Active Pharmaceutical Ingredients) Industry Opportunities and Challenges
- 9.4 Natural APIs (Active Pharmaceutical Ingredients) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst